What is Genecis?
Genecis Bioindustries operates at the intersection of biotechnology and material science, specializing in the production of PHA plastics derived from organic waste streams. The company provides a robust alternative to conventional single-use plastics, catering to diverse sectors including automotive, textiles, packaging, and medical devices. By offering comprehensive services such as polymer development and co-branding, Genecis enables enterprise partners to integrate eco-friendly materials into their product life cycles without sacrificing performance or profitability. This market-leading approach addresses the urgent demand for sustainable solutions that resonate with environmentally conscious consumers and regulatory frameworks alike.
How much funding has Genecis raised?
Genecis has raised a total of $10M across 2 funding rounds:
Series A
$7M
Debt
$3M
Series A (2022): $7M with participation from BDC Capital Management, AME Cloud Ventures, Khosla Ventures Acquisition, and Gullspång Re:food
Debt (2022): $3M led by Silicon Valley Bank
Key Investors in Genecis
BDC Capital Management
BDC Capital Management is an independent investment advisory firm specializing in comprehensive financial planning and values-based investing, prioritizing objective, relationship-driven advice for long-term financial goals.
AME Cloud Ventures
Led by Yahoo! co-founder Jerry Yang, AME Cloud Ventures focuses on data-centric infrastructure and technology-heavy companies, providing operational expertise and a global network to support high-growth ventures.
Gullspång Re:food
Re:food is a transatlantic growth equity investor dedicated to supporting visionary agrifood companies that drive sustainable change and address critical challenges within the global food system.
What's next for Genecis?
With this recent infusion of capital, Genecis is well-positioned to accelerate its operational scaling and expand its reach within the global sustainable materials market. The company's strategic roadmap likely involves increasing production capacity for its PHA-based polymers and deepening its collaborative efforts with major industrial partners. As the firm moves beyond its initial development phases, the focus will shift toward optimizing supply chain efficiencies and broadening its portfolio of high-performance, bio-based alternatives. This trajectory suggests a long-term commitment to establishing a dominant footprint in the green technology landscape, ensuring that circular economy principles become the standard for future industrial production.
See full Genecis company page
